Medical Device Maker Alamar Bio Boosts IPO to Raise $191 Million

Posted by MarketsWire

Alamar Biosciences Inc., a maker of medical devices that detect protein biomarkers to diagnose diseases, raised $191 million in an upsized US initial public offering that priced at the top of a marketed range.

1 replies

tomspark wrote:

Protein biomarker detection is a solid play if their tech actually works, but medical device IPOs are brutal — regulatory risk, reimbursement cycles, and competition from established players. Worth watching the earnings calls to see if they have real differentiation or if this is just riding the biotech hype wave.